TITLE

Effectiveness of smoking cessation therapies: a systematic review and meta-analysis

AUTHOR(S)
Ping Wu; Wilson, Kumanan; Dimoulas, Popey; Mills, Edward J.
PUB. DATE
January 2006
SOURCE
BMC Public Health;2006, Vol. 6, p300
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Smoking remains the leading preventable cause of premature deaths. Several pharmacological interventions now exist to aid smokers in cessation. These include Nicotine Replacement Therapy [NRT], bupropion, and varenicline. We aimed to assess their relative efficacy in smoking cessation by conducting a systematic review and meta-analysis. Methods: We searched 10 electronic medical databases (inception to Sept. 2006) and bibliographies of published reviews. We selected randomized controlled trials [RCTs] evaluating interventions for smoking cessation at 1 year, through chemical confirmation. Our primary endpoint was smoking cessation at 1 year. Secondary endpoints included short-term smoking cessation (∼3 months) and adverse events. We conducted random-effects meta-analysis and meta-regression. We compared treatment effects across interventions using head-to-head trials and when these did not exist, we calculated indirect comparisons. Results: We identified 70 trials of NRT versus control at 1 year, Odds Ratio [OR] 1.71, 95% Confidence Interval [CI], 1.55-1.88, P =< 0.0001). This was consistent when examining all placebo-controlled trials (49 RCTs, OR 1.78, 95% CI, 1.60-1.99), NRT gum (OR 1.60, 95% CI, 1.37-1.86) or patch (OR 1.63, 95% CI, 1.41-1.89). NRT also reduced smoking at 3 months (OR 1.98, 95% CI, 1.77-2.21). Bupropion trials were superior to controls at 1 year (12 RCTs, OR1.56, 95% CI, 1.10-2.21, P = 0.01) and at 3 months (OR 2.13, 95% CI, 1.72-2.64). Two RCTs evaluated the superiority of bupropion versus NRT at 1 year (OR 1.14, 95% CI, 0.20-6.42). Varenicline was superior to placebo at 1 year (4 RCTs, OR 2.96, 95% CI, 2.12-4.12, P =< 0.0001) and also at approximately 3 months (OR 3.75, 95% CI, 2.65-5.30). Three RCTs evaluated the effectiveness of varenicline versus bupropion at 1 year (OR 1.58, 95% CI, 1.22-2.05) and at approximately 3 months (OR 1.61, 95% CI, 1.16-2.21). Using indirect comparisons, varenicline was superior to NRT when compared to placebo controls (OR 1.66, 95% CI 1.17-2.36, P = 0.004) or to all controls at 1 year (OR 1.73, 95% CI 1.22-2.45, P = 0.001). This was also the case for 3-month data. Adverse events were not systematically different across studies. Conclusion: NRT, bupropion and varenicline all provide therapeutic effects in assisting with smoking cessation. Direct and indirect comparisons identify a hierarchy of effectiveness.
ACCESSION #
29362437

 

Related Articles

  • Correction: A Text Messaging-Based Smoking Cessation Program for Adult Smokers: Randomized Controlled Trial. Ybarra, Michele; Bosi, A Tülay Bağci; Korchmaros, Josephine; Emri, Salih // Journal of Medical Internet Research;Jun2015, Vol. 17 Issue 6, p1 

    A correction to the article "A Text Messaging-Based Smoking Cessation Program for Adult Smokers: Randomized Controlled Trial" published in a previous issue of the periodical is presented.

  • Thinking about going to the dentist: a Contemplation Ladder to assess dentally-avoidant individuals' readiness to go to a dentist. Coolidge, Trilby; Skaret, Erik; Heima, Masahiro; Johnson, Elissa K.; Hillstead, M. Blake; Farjo, Nadia; Asmyhr, Oyvind; Weinstein, Philip // BMC Oral Health;2011, Vol. 11 Issue 1, p4 

    Background: The Transtheoretical Model suggests that individuals vary according to their readiness to change behavior. Previous work in smoking cessation and other health areas suggests that interventions are more successful when they are tailored to an individual's stage of change with regards...

  • Optimal Carbon Monoxide Criteria to Confirm 24-hr Smoking Abstinence. Perkins, Kenneth A.; Karelitz, Joshua L.; Jao, Nancy C. // Nicotine & Tobacco Research;May2013, Vol. 15 Issue 5, p978 

    Introduction: Smoking cessation is typically verified biochemically by expired-air carbon monoxide (CO) levels below 9 ppm (i.e., ≤8 ppm), but this CO criterion may lead many who have smoked within 24hr to be misclassified as abstinent. Methods: Adult dependent smokers (N = 261; 124 men,...

  • Impact of Genetic Notification on Smoking Cessation: Systematic Review and Pooled-Analysis. de Viron, Sylviane; Van der Heyden, Johan; Ambrosino, Elena; Arbyn, Marc; Brand, Angela; Van Oyen, Herman // PLoS ONE;Jul2012, Vol. 7 Issue 7, p1 

    Objectives: This study aimed to evaluate the impact of genetic notification of smoking-related disease risk on smoking cessation in the general population. Secondary objectives were to assess the impact of genetic notification on intention-toquit smoking and on emotional outcomes as well as the...

  • Four-week pre-quit varenicline ups success rate.  // Pulse;5/18/2011, Vol. 71 Issue 18, p11 

    The article reports on the increase in success rate of smokers who want to quit smoking when using varenicline for four weeks rather than one week before their quit date.

  • Smoking cessation plan shows short-term cost benefits in HK.  // PharmacoEconomics & Outcomes News;7/24/2010, Issue 608, p6 

    The article discusses research study on the cost effectiveness of a low-intensity smoking cessation programme, referencing a study by S. S. Chan and colleagues presented at the 17th World Congress of Cardiology.

  • Combining treatments increases success rates for smoking cessation.  // Healthy Years;Aug2014, Vol. 11 Issue 8, p2 

    The article reports on the results of the study published in the "Journal of Psychiatry" which revealed that combination of smoking-cessation therapies increases the chances of success for men and highly nicotine-dependent smokers.

  • Quitters referring smokers: a quitline chain-referral pilot study. DeLaughter, Kathryn L.; Volkman, Julie E.; Phillips, Barrett D.; Houston, Thomas K. // BMC Research Notes;2014, Vol. 7 Issue 1, p2 

    Background Telephone counseling Quitlines can support smoking cessation, but are under-utilized. We explored the use of smoker peer-referrals to increase use of a Quitline in Mississippi and Alabama. Findings Collaborating with the Alabama and Mississippi Quitline, we piloted peer-referrals to...

  • 10 fast facts about quitting smoking.  // Asian Pacific Post;6/25/2015, p7 

    This article offers facts about quitting smoking, including quitting smoking is the single best thing smokers can do for their health, one to nine months after quitting, smokers cough less, and 10 years after quitting, a smoker's chances of dying from lung cancer are much lower.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics